InnoCan Pharma Corporation (QB) (INNPF)
USOTC
The current INNPF market cap is 25.48M. The company's latest EPS is USD -0.0167 and P/E is -5.39.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 8k | 196k | 2.56M | 13.66M |
Operating Income | -2.77M | -4.5M | -7.27M | -5.81M | -3.51M |
Net Income | -3.34M | -9.95M | -10.05M | -3.76M | -4.7M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.58M | 4.33M | 12.58M | 6.98M | 6.94M |
Total Liabilities | 1.17M | 7.94M | 3.56M | 751k | 2.55M |
Total Equity | 1.41M | -3.61M | 9.01M | 6.23M | 4.39M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.72M | -3.69M | -6.63M | -6.07M | -3.9M |
Investing | -9k | N/A | -48k | -31k | -84k |
Financing | 4.45M | 4.02M | 15.3M | 125k | 2.92M |
Market Cap | 25.48M |
Price to Earnings Ratio | -5.39 |
Price to Sales Ratio | 1.85 |
Price to Cash Ratio | 6.52 |
Price to Book Ratio | 5.76 |
Dividend Yield | - |
Shares Outstanding | 280.66M |
Average Volume (1 week) | 250 |
Average Volume (1 Month) | 8.83k |
52 Week Change | -61.36% |
52 Week High | 0.30 |
52 Week Low | 0.0908 |
Spread (Intraday) | 0.17 (69.78%) |
Company Name | InnoCan Pharma Corporation (QB) |
Address |
1015, 926 - 5 avenue sw calgary, alberta T2P 0N7 |
Website | https://www.innocanpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.